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Background: The adaptive immune response to colorectal cancer is important for survival. Less is understood
about the role of innate lymphocytes, such as Natural Killer (NK) cells, which are abundant in human liver.
Methods: Samples of fresh liver (n = 21) and tumour (n = 11) tissue were obtained from patients undergoing
surgical resection of colorectal liver metastases. Flow cytometry was used to analyse the presence and phenotype
of NK cells, as compared to T cells, in the tumour and liver tissue. Results were correlated with survival.
Results: NK cells were poorly recruited to the tumours (distant liver tissue 38.3%, peritumoural liver 34.2%, tumour
12.9%, p = 0.0068). Intrahepatic and intratumoural NK cells were KIR (killer immunoglobulin-like receptor)loNKG2Ahi
whereas circulating NK cells were KIRhiNKG2Alo. By contrast T cells represented 65.7% of the tumour infiltrating
lymphocytes. Overall survival was 43% at 5 years, with the 5-year survival for individuals with a T cell rich infiltrate being
60% (95% CI 17-93%) and for those with a low T cell infiltrate being 0% (95% CI 0-48%). Conversely individuals with
higher levels of NK cells in the tumour had an inferior outcome, although there were insufficient numbers to reach
significance (median survivals: NKHi 1.63 years vs NKLo 3.92 years).
Conclusions: T cells, but not NK cells, are preferentially recruited to colorectal liver metastases. NK cells within colorectal
metastases have an intrahepatic and potentially tolerogenic, rather than a peripheral, phenotype. Similar to primary
tumours, the magnitude of the T cell infiltrate in colorectal metastases is positively associated with survival.
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CD56+ T cellsBackground
The liver is the most common site of metastasis of colo-
rectal cancer. When surgical resection of liver metastases
is possible, the median five-year survival now approaches
40% [1]. For those who do not survive this is almost always
due to disease recurrence. A number of factors are known
to influence the prognosis of patients with colorectal liver
metastases such as stage of primary disease, synchronous
presentation, number of metastases, and carcinoembryonic
antigen level [2,3]. There is also increasing evidence that
the host response to colorectal cancer is relevant to disease
progression and survival [4-8]. Whilst the majority of such
evidence concerns stage I-III disease, there is emerging* Correspondence: S.Pugh@soton.ac.uk
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reproduction in any medium, provided the ordata, albeit limited, for the role of immunosurveillance in
colorectal liver metastases [9-11]. One study reported more
CD8 T cells and less CD4 T cells in the metastases of pa-
tients surviving ≥10 years post liver resection compared to
≤2 year survivors [9]. In addition there is evidence that a
high number of regulatory T cells relative to CD4 or CD8
T cells is predictive of a poor outcome which is in accord-
ance with data from primary colorectal cancer [10,11].
To date it is primarily cells of the adaptive immune
system that are understood to be key in determining
outcome from colorectal cancer [4,6,8,10-12]. The liver
however has a unique immunological environment in
which the lymphoid population is weighted with innate im-
mune cells [12,13]. Within the liver Natural Killer (NK)
cells are the predominant innate lymphocyte population
accounting for up to 50% of human hepatic lymphocytestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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eral blood [14-16]. These lymphocytes are potent anti-
tumour effector cells both through an ability to directly kill
target cells without the need for prior sensitisation, and
also secrete cytokines that influence the adaptive immune
response [17]. In addition the liver has a high prevalence of
CD56+ T cells [13,15]. These CD56+CD3+ lymphocytes are
also capable of mediating target cell lysis in the absence of
prior immunisation with antigen.
The relative abundance of innate lymphocytes in
human liver should represent a significant defence to
hepatic malignancy. However, as a site of early encoun-
ter of antigens the liver must be tolerogenic to dietary
antigens and commensal organisms at the same time as
being able to mount an effective immune response to
pathogens or tumour cells [18,19]. As such it is thought
that hepatic tolerance may be favoured over the induc-
tion of immunity. Indeed allogeneic liver transplants
across fully incompatible HLA (human leukocyte antigen)
barriers sometimes survive without the need for immuno-
suppression [20].
This study sought to determine the relative contribu-
tion of innate versus adaptive immunity to the hepatic
defence against colorectal metastasis. The relative re-
cruitment of Natural Killer cells, CD56+ T cells and
CD56− T cells to colorectal liver metastases was ana-
lysed and correlated with long-term survival. This was
determined using flow cytometry to allow accurate ana-
lysis of the lymphocyte subsets in fresh tissue collected
from patients undergoing resection of metastatic disease
in the liver.
Methods
Study population
A total of 21 patients undergoing surgical resection of
their liver for colorectal metastasis at Southampton
General Hospital, Southampton, UK between July 2006
and October 2007 were included. Patients were between
40 and 80 years of age and 13 were male. Ethical permis-
sion was obtained from the Southampton and South
West Hampshire Research Ethics Committee. Written
informed consent was obtained from all participants. At
a median follow up of 6.5 years, 12 patients were still
alive, eight had died of disease and one died of transi-
tional cell carcinoma of the bladder. The median survival
for the whole cohort was 3.92 years with a five year over-
all survival of 43% (95% CI 23%-66%). An additional 17
healthy controls, 10 male mean age 37 years, gave con-
sent for the use of peripheral blood and were included.
Isolation of lymphocytes from liver/tumour tissue
Samples of fresh liver only (n = 21) and paired liver and
tumour tissue (n = 11) were obtained following surgical
resection, placed in liver solution, [21] and processedimmediately. These were macroscopically divided into
tumour tissue, peritumoural liver tissue (defined as the
liver tissue immediately adjacent to the tumour) and liver
tissue distant from the tumour site (>5 cm from the
tumour). The tissue was dissected into approximately
2 mm3 fragments and the total mass recorded for later
determination of the number of mononuclear cells/mg
of tissue. Following this, collagenase type IV (Sigma,
Poole, UK) and DNase I (Sigma, Poole, UK) at final
concentrations of 0.05% and 0.002% respectively were
added to the dissected tissue. Samples were incubated
at 37°C for 30 minutes on an orbital shaker. Undis-
sociated tissue was removed by filtering the samples
through a 70 μm cell strainer (Becton Dickinson, Oxford,
UK). Ficoll density gradient centrifugation was used to iso-
late the mononuclear cells followed by trypan blue exclu-
sion to count the live cells.
In order to ascertain that this process of enzymatic di-
gestion did not result in a loss of phenotypic markers
this method was directly compared to a purely mechan-
ical method of dissociation. Not only did the enzymatic
method yield consistently higher numbers of mono-
nuclear cells, flow cytometric analysis confirmed that
there was no loss of phenotypic marker expression (data
not shown).
Isolation of mononuclear cells from whole blood
Samples of matched blood were obtained from seven pa-
tients prior to surgery. Blood was diluted 1:1 with RPMI
and layered on an equal volume of Ficoll for density gra-
dient centrifugation. Trypan blue exclusion was used as
described above.
Flow cytometry
Immunophenotypic analysis was performed using three
colour flow cytometry on a FACS Calibur (Becton
Dickinson) and six colour flow cytometry on a FACS Canto
(Becton Dickinson). Antibodies used were CD45 FITC,
2DL2/3 FITC, CD56 PE, NKG2D PE, CD3 PerCP, Strepta-
vidin PerCP, CD56 PE-Cy7, 2DL1 APC, CD56 APC, CD3
APC-Cy7, 3DL1 biotin (all Becton Dickinson). Ig isotype
controls were used where appropriate. Lymphocyte gating
was performed using the forward scatter versus side scatter
plot and 10 000 events were acquired. NK cells were iden-
tified as CD3−CD56+, T cells as CD3+CD56−, and CD56+ T
cells as CD3+CD56+. Data was analysed using Cell Quest/
FACS Diva software.
Statistical methods
Statistical analyses were performed using GraphPad Prism
version 5 (GraphPad, La Jolla, CA, USA). Comparisons
were made using non-parametric tests (Mann–Whitney
U-test and Kruskal Wallis test) to assess differences in
the expression of phenotypic markers by lymphocytes
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Meier plots were analysed using the log-rank test.
Results
We evaluated the frequencies of NK cells, T cells
and CD56+ T cells in the macroscopically unaffected
(“distant”) liver, the peritumoural liver and within the
tumour tissue itself using flow cytometry (Figure 1).
Consistent with previous reports and of the model that
the liver is an innate organ there were fewer CD56− T
cells (42.5% vs 62.2% p = 0.018), but more CD56+ T
cells (21% vs 4.9%, p = 0.053) and CD56+ NK cells
(19.7% vs 13.6% p = ns) in the macroscopically un-
affected liver than peripheral blood. As such there was
a higher ratio of T cells to NK cells in peripheral bloodFigure 1 Flow cytometry was used to determine the subsets of
lymphocytes present in liver, tumour and peripheral blood.
Shown are two dot plots demonstrating the gating using forward
scatter and side scatter (A), and CD56 versus CD3 (B) demonstrating
the populations of NK cells, T cells, and CD56+ T cells.as compared to liver tissue in all but one of seven pa-
tients (Figure 2A).
Overall we found no difference in the frequencies of
lymphocytes between the distant and peritumoural
liver tissue (NK cells: distant liver 38%, peritumoural
liver 34%, T cells: distant liver 36%, peritumoural liver
45%, CD56+ T cells: distant liver 13%, peritumoural
liver 12%) (Figures 2B, D, F). However we noted that
the lymphocyte population within the tumour was
substantially different from the background liver, with an
increased frequency of T cells (61.8% vs 37.4% p = 0.0008)
and a depressed frequency of NK cells (12.9% vs 38.3%
p = 0.0048) and CD56+ T cells (6.7% vs 13.1% p =0.03).
Furthermore the absolute number of CD56− T cells
was similar at all three sites sampled (macroscopically
normal liver tissue, 595 cells/mg, peritumoural liver
760 cells/mg and tumour 626 cells/mg p = ns), whilst
the intratumoral NK cell number was significantly lower
than the macroscopically normal tissue (145 cells/mg
vs 832 cells/mg p = 0.026) and there was a trend to-
wards a lower number of CD56+ T cells in the tumour
(92 cells/mg) compared to the macroscopically normal
liver (285 cells/mg) (Figures 2C, E, G). Thus there ap-
pears to be a preferential recruitment of T cells, rather
than NK cells or CD56+ T cells to the tumour. To in-
vestigate further the relative paucity of NK cells within
the tumour we phenotyped them in more detail. This
showed that the intratumoural NK cells have an expres-
sion profile more similar to that found in the intrahepatic,
rather than peripheral blood compartment. In particular
NK cells in the liver and the tumour were relatively KIR
(killer immunoglobulin-like receptor) lo (median% of NK
cells expressing KIR2DL1 and KIR2DL2/3 in: liver 4.5%
and 15.1%, tumour 3.1% and 13.5%, peripheral blood 25%
and 36.7%) and NKG2Ahi (median% of NK cells express-
ing NKG2A: liver 65%, tumour 65%, peripheral blood
46%) when compared with NK cells isolated from periph-
eral blood (Figure 3). Thus either there is a modest influx
of NK cells from the liver, or the tumour microenviron-
ment is more conducive to recruitment of NKG2Ahi
NK cells.
NKG2D is an activating NK cell receptor, also ex-
pressed by cytotoxic T cells, that is downregulated in the
presence of colorectal cancer due to the shedding of
MIC-A/B by the tumour [22,23]. This may be one mech-
anism of immune evasion by colorectal cancer. However
NKG2D expression was maintained on NK cells isolated
from peripheral blood of patients with colorectal liver
metastases (median% of NK cells expressing NKG2D
from peripheral blood of patients with metastases 81.6%
vs healthy volunteers 84.9%, p = 0.98), and also on the
tumour infiltrating NK cells (median 92.6%) indicating
that NKG2D downregulation was not a cause for the
weak NK cell response (Figure 4).
CD56+ T cells
%
 o
f l
ym
ph
oc
yt
es
Distant liver Peritumoural liver Centre of tumour
0
10
20
30
40
T cells
Distant liver Peritumoural liver Centre of tumour
0
20
40
60
80
100
%
 o
f l
ym
ph
oc
yt
es
NK cells
Distant liver Peritumoural liver Centre of tumour
0
20
40
60
80
100
%
 o
f l
ym
ph
oc
yt
es
p= 0.0048
p=0.0008
p= 0.0256
p= 0.03
A
C
F
ED
B
G
Figure 2 Liver tissue, tumour tissue and peripheral blood samples were analysed for the presence of NK cells (CD56+CD3−), T cells
(CD3+CD56−) and CD56+ T cells (CD56+CD3+) by flow cytometry. A The ratio of T cells to NK cells in distant liver tissue and peripheral blood
(PBMC) is presented for seven patients in whom matched blood samples were obtained. The percentages (B, D, F) and actual numbers (C, E, G) of NK
cells (CD56+CD3−), T cells (CD3+CD56−), and CD56+ T cells (CD56+CD3+) in the tumour, peritumoural liver and distant liver tissue were determined in
11 patients.
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Figure 3 Expression of the NK cell markers NKG2D (A), NKG2A (B), KIR2DL1 (C) and KIR2DL2/3 (D) as determined by flow cytometry of
NK cells isolated from liver tissue, tumour and PBMC.
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the intratumoural lymphocyte infiltrate had an impact
on outcome we divided the patients into two groups
“Hi” and “Lo” depending on whether the lymphocyte
composition was greater or less than the median value
of the population. Patients were followed up for a mini-
mum of 5.8 years and the outcome data correlated to
the lymphocyte frequencies (Figure 5). Patients with a T
cell rich intratumoural infiltrate had improved survival
as compared to those with low levels of T cell infiltration
(p = 0.0182 Figure 5C). Conversely those with a low NK
cell infiltrate had improved survival. There was no influ-
ence of peritumoural lymphocytes on outcome. Previousp= 0.98
A
Figure 4 NKG2D expression by NK cells (A) and T cells (B) from PBMC
controls as determined by flow cytometry.studies have utilised immunohistochemical based ana-
lyses and as such calculated numbers of lymphocytes ra-
ther than frequencies, however, we found no correlation
between absolute numbers of T cells or NK cells and
survival (data not shown). Overall, our data suggest that
a strong T cell, but not NK cell or CD56+ T cell response
to the tumour is associated with a favourable prognosis.
Discussion
The normal liver must remain tolerogenic to a multitude
of harmless antigens from the gut whilst retaining vigi-
lance to toxins and tumour cells [18,19]. This results in
a unique immunological environment rich in cells of theB
p=0.0795
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Figure 5 Kaplan-Meier plots of overall survival of patients according to Hi (greater than or equal to the median) or Lo (lower than the
median) proportions of NK cells (CD56+CD3−) (A, B), T cells (CD56−CD3+) (C, D), or CD56+ T (CD56+CD3+) cells (E, F) in the tumour of 11
patients and peritumoral liver tissue of 20 patients.
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of NK cells and CD56+ T cells [13,14]. NK cells are lym-
phocytes originally defined based on their prompt spon-
taneous killing of malignant cells [24]. This relative
abundance of NK cells and CD56+ T cells, both with po-
tent anti-tumour functions, should represent a substan-
tial defence against metastasis to the liver. Indeed our
initial hypothesis was that there would be a gradient
across the liver, between distant and peritumoural liver
tissue, indicative of migration of hepatic NK cells to-
wards the tumour. Whilst our findings confirm that
livers containing colorectal metastases are relatively rich
in these innate lymphocyte subsets, these data suggest
that they contribute little to the immunological defence
against these tumours since no evidence was found of
migration and there was a paucity of intratumoural NK
and CD56+ T cells. In our initial studies we also
hypothesised that invariant NKT cells expressing the
receptor Vα24Jα18 may be involved in the response
to hepatic malignancy. However they were present in
frequencies lower than 1% (data not shown), consistent
with the observations of others, [25] and therefore we did
not pursue this further.
Interestingly the few NK cells that were isolated from
the tumour tissue had a similar phenotype to those in
the macroscopically normal liver, rather than the periph-
eral blood, being NKG2Ahi and KIRlo. This suggests that
the tumour has “escaped” the intrahepatic NK cell re-
sponse consistent with the model that there is immune
editing of the tumour within the liver.
Our observations that a higher infiltrate of T cells
(CD3+CD56−) to the tumour correlates positively with
an improved survival is in concordance with published
data in both primary colorectal cancer and colorectal
liver metastases using immunohistochemistry [4,8-10].
In this study we utilised flow cytometry, instead of the
commonly used immunohistochemical analysis of FFPE
tissue, in order to examine the lymphocyte subsets
present in fresh liver and tumour tissue. This allowed
the analysis of much larger quantities of tissue avoiding
the potential sampling bias due to heterogeneity of the
lymphocytic infiltrate. Furthermore the use of fresh tis-
sue taken at the time of resection enabled pieces of spe-
cimen to be selected, such as peritumoural and distant
liver tissue, rather than being limited by stored tissue. In
fact we observed that the intratumoural as opposed to
the peritumoural liver T lymphocyte response is import-
ant in determining outcome. Data from primary colorec-
tal cancer has shown both the lymphocyte infiltrate at
the invasive margin as well as the centre of the tumour
to correlate with survival [4]. However in our study peri-
tumoural liver was examined since liver metastases tend
to have what is described as a pushing margin rather
than an invasive margin. The finding that higher NKcell levels are associated with a worse outcome is con-
sistent with recent reports of NK cell “fratricide” of
antigen specific T cells and thus can attenuate adaptive
immunity [26,27].
It has been shown by a number of authors that a
higher number of T cells infiltrating the tumour is a pre-
dictor of superior survival. This benefit does however
appear to be dependent upon the relative proportions of
T cell subsets present, with a higher number of regula-
tory T cells proportional to CD4 or CD8 T cells predict-
ive of a worse outcome [10]. In this study we did not
analyse the T cell subsets, other than to look at CD56+ T
cells, the proportion of which did not correlate with sur-
vival. These are an innate sub-population of T cells
which are relatively enriched in the liver. The absence of
an association of these lymphocytes with outcome is
consistent with our observation that the intrahepatic
lymphocyte microenvironment does not appear to play a
significant role in the immune response to colorectal
liver metastasis.
We have shown that NK cells poorly infiltrate the
tumour as compared with other lymphocytes such as T
cells. The phenotypic similarities between the hepatic
and intratumoural NK cells may suggest the NK cells
that do infiltrate the tumour are derived from the hep-
atic population. What we now understand, both from
our own and others data, is that these hepatic NK cells
are functionally distinct from circulating NK cells [28].
Hepatic NK cells have decreased cytotoxic function both
because of a higher percentage of CD56bright (CD16−)
NK cells and overall decreased cytolytic activity of the
CD56dim (CD16+) NK cells. One hypothesis is that this
is due to fewer licensed NK cells within the liver thereby
resulting in a functionally hyporesponsive population.
It is perhaps more challenging to acknowledge that
those patients with a higher infiltrate of NK cells to the
tumour appear to have an inferior outcome following re-
section. However, given that the liver is continuously
confronted with a large antigenic load, much of which is
harmless, immune responses must be carefully regulated
and it appears that there is an overall tendency towards
tolerance rather than immunity. Therefore rather than
hepatic NK cells providing a strong anti-tumour defence,
it may be that this “tolerant” population contributes to
the susceptibility of the liver to metastatic disease.
Conclusion
In conclusion we have shown that despite a relative
abundance of NK cells in the liver, there is a preferential
recruitment of T cells rather than NK cells to colorectal
liver metastases. This poor infiltration, together with the
trend suggesting a negative correlation with survival,
likely reflects a tendency towards tolerance of hepatic
NK cells rather than immunity. By contrast there is a
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tumour and survival post liver resection. If this can
be validated in a larger cohort of patients it may be
utilised to predict likelihood of recurrence following
resection of colorectal liver metastases with curative
intent.
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